Cite
MLA Citation
C.S. Diefenbach et al.. “EXTENDED FOLLOW‐UP OF A PHASE I TRIAL OF IPILIMUMAB, NIVOLUMAB AND BRENTUXIMAB VEDOTIN IN RELAPSED HODGKIN LYMPHOMA: A TRIAL OF THE ECOG‐ACRIN RESEARCH GROUP (E4412).” Hematological oncology, vol. 37, n.d., pp. 123–124. http://access.bl.uk/ark:/81055/vdc_100086193058.0x000044